Finding could potentially make iPS cells safer for use in humansPhys.OrgThey did so by fusing mouse embryonic stem cells with a human skin cell, or fibroblast, to create a bi-species product, called a heterokaryon, with a 3:1 nuclear ratio, skewed toward the stem cells. This ratio shifts the balance of cellular proteins to … and … Continue reading
Stem Cell Therapeutics Advances CD47 Antagonist Program Into IND-Enabling …StockhouseTORONTO, ONTARIO–(Marketwired – Sept. 9, 2013) – Stem Cell Therapeutics Corp. (TSX VENTURE:SSS)(OTCQX:SCTPF), a biopharmaceutical company developing cancer stem cell– related therapeutics, today announced that it has advanced its CD47 … and more …read more &nbs… Continue reading
Stem Cell Therapeutics Advances CD47 Antagonist Program Into IND-Enabling …Marketwire (press release)TORONTO, ONTARIO–(Marketwired – Sept. 9, 2013) – Stem Cell Therapeutics Corp. (TSX VENTURE:SSS)(OTCQX:SCTPF), a biopharmaceutical company developing cancer stem cell– related therapeutics, today announced that it has advanced its CD47 … and more …read more &nbs… Continue reading
Stem Cell Therapeutics Advances CD47 Antagonist Program Into IND-Enabling …MENAFN.COMTORONTO, ONTARIO, Sep 09, 2013 (Menafn – Marketwired via COMTEX) —Stem Cell Therapeutics Corp. (otcqx:SCTPF), abiopharmaceutical company developing cancer stem cell– relatedtherapeutics, today announced that it has advanced its … …read more &nbs… Continue reading
Research and Markets: Cancer Stem Cells Drug Pipeline Update 2013The Herald | HeraldOnline.comTreatments designed to target and destroy cancer stem cells may come to revolutionize how we treat cancer. This unique product covers both explicit cancer stem cell drug development and cancer drugs which are inhibitors of the Hedgehog, Notch, and WNT … and more … Continue reading
Study Indicates Benefits of Stem Cells in Treating MS Declines With Donor’s AgeDigitalJournal.comAs stem cell clinical trials for multiple sclerosis (MS) patients become more common, it is crucial for researchers to understand the biologic changes and therapeutic effects of older donor stem cells. A new study appearing in the latest issue of STEM … …read … Continue reading
Study Indicates Benefits of Stem Cells in Treating MS Declines With Donor’s AgePR Web (press release)As stem cell clinical trials for multiple sclerosis (MS) patients become more common, it is crucial for researchers to understand the biologic changes and therapeutic effects of older donor stem cells. A new study appearing in the latest issue of … Continue reading
RESEARCH AND MARKETS: Cancer Stem Cells Drug Pipeline Update 20134-traders (press release)Treatments designed to target and destroy cancer stem cells may come to revolutionize how we treat cancer. This unique product covers both explicit cancer stem cell drug development and cancer drugs which are inhibitors of the Hedgehog, Notch, and WNT … …read more &nbs… Continue reading